Thanks to visit codestin.com
Credit goes to link.springer.com

Skip to main content
Springer Nature Link
Log in

Interaction analysis of IL-12A and IL-12B polymorphisms with the risk of colorectal cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

IL-12 is an antitumor cytokine with functions of inhibiting tumor growth, invasion, and metastasis, indicating that IL-12 is a promising candidate for cancer treatment. The aim of this study was to investigate the association of IL-12A rs568408, IL-12A rs2243115, and IL-12B rs3212227 with the susceptibility to colorectal cancer (CRC). Two hundred and fifty-seven histopathologically confirmed CRC patients and 236 age- and gender-matched controls were enrolled. The three polymorphisms were genotyped using a polymerase chain reaction–restriction fragment length polymorphism assay. We found that the IL-12A rs568408 AG/AA genotypes were associated with an increased risk of CRC with an adjusted odds ratio (OR) of 1.66 (95 % confidence interval (CI), 1.11–2.48). Stratified analyses showed that patients carrying the IL-12B rs3212227AC/CC genotypes had a 1.97-fold increased risk of tumor metastasis (OR = 1.97; 95 % CI, 1.04–3.70). Gene–gene interaction analysis showed that subjects carrying the IL-12A rs568408AG/AA and IL-12B rs3212227AA genotypes had a 2.40-fold increased risk of CRC (OR = 2.40; 95 % CI, 1.14–5.07) and individuals carrying the IL-12A rs568408AG/AA and IL-12B rs3212227AC/CC genotypes had a 1.93-fold increased risk of CRC (OR = 1.93; 95 % CI, 1.10–3.41). These findings indicate that IL-12A rs568408 and IL-12B rs3212227 may be related to the development of CRC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+
from £29.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Explore related subjects

Discover the latest articles, books and news in related subjects, suggested using machine learning.

References

  1. Perwez Hussain S, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 2007;121(11):2373–80.

    Article  PubMed  Google Scholar 

  2. Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138(2):746–74. 74 e1-4, quiz e12-3.

    Article  PubMed  Google Scholar 

  3. Bae SI, Kim YS. Colon cancer screening and surveillance in inflammatory bowel disease. Clin Endosc. 2014;47(6):509–15.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Lukas M. Inflammatory bowel disease as a risk factor for colorectal cancer. Dig Dis. 2010;28(4-5):619–24.

    Article  PubMed  Google Scholar 

  5. Herszenyi L, Barabas L, Miheller P, Tulassay Z. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk. Dig Dis. 2015;33(1):52–7.

    Article  PubMed  Google Scholar 

  6. Basavaraju U, Shebl FM, Palmer AJ, Berry S, Hold GL, El-Omar EM, et al. Cytokine gene polymorphisms, cytokine levels and the risk of colorectal neoplasia in a screened population of Northeast Scotland. Eur J Cancer Prev. 2015;24(4):296–304.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Cui G, Qi H, Gundersen MD, Yang H, Christiansen I, Sorbye SW, et al. Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer. Cancer Immunol Immunother. 2015;64(2):181–90.

    Article  CAS  PubMed  Google Scholar 

  8. Gao LB, Rao L, Wang YY, Liang WB, Li C, Xue H, et al. The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. Carcinogenesis. 2009;30(2):295–9.

    Article  CAS  PubMed  Google Scholar 

  9. Lasek W, Zagozdzon R, Jakobisiak M. Interleukin 12: still a promising candidate for tumor immunotherapy? Cancer Immunol Immunother. 2014;63(5):419–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Stanilov NS, Miteva LD, Dobreva ZG, Jovchev JP, Cirovski GM, Stanilova SA. Monocytes expression of IL-12 related and IL-10 genes in association with development of colorectal cancer. Mol Biol Rep. 2012;39(12):10895–902.

    Article  CAS  PubMed  Google Scholar 

  11. Nakayama Y, Sako T, Shibao K, Onitsuka K, Nagashima N, Hirata K, et al. Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer. Anticancer Res. 2000;20(6A):4097–102.

    CAS  PubMed  Google Scholar 

  12. McRae BL, Semnani RT, Hayes MP, van Seventer GA, Type I. IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J Immunol. 1998;160(9):4298–304.

    CAS  PubMed  Google Scholar 

  13. Bellone G, Turletti A, Artusio E, Mareschi K, Carbone A, Tibaudi D, et al. Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. Am J Pathol. 1999;155(2):537–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zhang Y, Ma CJ, Wang JM, Ji XJ, Wu XY, Jia ZS, et al. Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection. PLoS One. 2011;6(5), e19664.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Yin XL, Wang N, Wei X, Xie GF, Li JJ, Liang HJ. Interleukin-12 inhibits the survival of human colon cancer stem cells in vitro and their tumor initiating capacity in mice. Cancer Lett. 2012;322(1):92–7.

    Article  CAS  PubMed  Google Scholar 

  16. Satoh Y, Esche C, Gambotto A, Shurin GV, Yurkovetsky ZR, Robbins PD, et al. Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice. J Exp Ther Oncol. 2002;2(6):337–49.

    Article  CAS  PubMed  Google Scholar 

  17. Mazzolini G, Qian C, Xie X, Sun Y, Lasarte JJ, Drozdzik M, et al. Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12. Cancer Gene Ther. 1999;6(6):514–22.

    Article  CAS  PubMed  Google Scholar 

  18. Hiscox S, Hallett MB, Puntis MC, Jiang WG. Inhibition of cancer cell motility and invasion by interleukin-12. Clin Exp Metastasis. 1995;13(5):396–404.

    Article  CAS  PubMed  Google Scholar 

  19. Shen F, Li JL, Cai WS, Zhu GH, Gu WL, Jia L, et al. Interleukin-12 prevents colorectal cancer liver metastases in mice. Onco Targets Ther. 2013;6:523–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Malvicini M, Rizzo M, Alaniz L, Pinero F, Garcia M, Atorrasagasti C, et al. A novel synergistic combination of cyclophosphamide and gene transfer of interleukin-12 eradicates colorectal carcinoma in mice. Clin Cancer Res. 2009;15(23):7256–65.

    Article  CAS  PubMed  Google Scholar 

  21. Addison CL, Bramson JL, Hitt MM, Muller WJ, Gauldie J, Graham FL. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors. Gene Ther. 1998;5(10):1400–9.

    Article  CAS  PubMed  Google Scholar 

  22. Gonzalez-Aparicio M, Alzuguren P, Mauleon I, Medina-Echeverz J, Hervas-Stubbs S, Mancheno U, et al. Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice. Gut. 2011;60(3):341–9.

    Article  CAS  PubMed  Google Scholar 

  23. Emtage PC, Wan Y, Hitt M, Graham FL, Muller WJ, Zlotnik A, et al. Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models. Hum Gene Ther. 1999;10(5):697–709.

    Article  CAS  PubMed  Google Scholar 

  24. Chen X, Han S, Wang S, Zhou X, Zhang M, Dong J, et al. Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. Clin Cancer Res. 2009;15(1):400–5.

    Article  CAS  PubMed  Google Scholar 

  25. Han SS, Cho EY, Lee TS, Kim JW, Park NH, Song YS, et al. Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical cancer in Korean women. Eur J Obstet Gynecol Reprod Biol. 2008;140(1):71–5.

    Article  CAS  PubMed  Google Scholar 

  26. Roszak A, Mostowska A, Sowinska A, Lianeri M, Jagodzinski PP. Contribution of IL12A and IL12B polymorphisms to the risk of cervical cancer. Pathol Oncol Res. 2012;18(4):997–1002.

    Article  CAS  PubMed  Google Scholar 

  27. Navaglia F, Basso D, Zambon CF, Ponzano E, Caenazzo L, Gallo N, et al. Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals. J Med Genet. 2005;42(6):503–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Yin J, Wang X, Wei J, Wang L, Shi Y, Zheng L, et al. Interleukin 12B rs3212227 T > G polymorphism was associated with an increased risk of gastric cardiac adenocarcinoma in a Chinese population. Dis Esophagus. 2015;28(3):291–8.

    Article  CAS  PubMed  Google Scholar 

  29. Tao YP, Wang WL, Li SY, Zhang J, Shi QZ, Zhao F, et al. Associations between polymorphisms in IL-12A, IL-12B, IL-12Rbeta1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer. J Cancer Res Clin Oncol. 2012;138(11):1891–900.

    Article  CAS  PubMed  Google Scholar 

  30. Nieters A, Yuan JM, Sun CL, Zhang ZQ, Stoehlmacher J, Govindarajan S, et al. Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer. 2005;103(4):740–8.

    Article  CAS  PubMed  Google Scholar 

  31. Liu L, Xu Y, Liu Z, Chen J, Zhang Y, Zhu J, et al. IL12 polymorphisms, HBV infection and risk of hepatocellular carcinoma in a high-risk Chinese population. Int J Cancer. 2011;128(7):1692–6.

    Article  CAS  PubMed  Google Scholar 

  32. Huang ZQ, Wang JL, Pan GG, Wei YS. Association of single nucleotide polymorphisms in IL-12 and IL-27 genes with colorectal cancer risk. Clin Biochem. 2012;45(1-2):54–9.

    Article  CAS  PubMed  Google Scholar 

  33. Miteva L, Stanilov N, Deliysky T, Mintchev N, Stanilova S. Association of polymorphisms in regulatory regions of interleukin-12p40 gene and cytokine serum level with colorectal cancer. Cancer Invest. 2009;27(9):924–31.

    Article  CAS  PubMed  Google Scholar 

  34. Lee KM, Shen M, Chapman RS, Yeager M, Welch R, He X, et al. Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei. China Carcinogenesis. 2007;28(7):1437–41.

    Article  CAS  PubMed  Google Scholar 

  35. Ebadi N, Jahed M, Mivehchi M, Majidizadeh T, Asgary M, Hosseini SA. Interleukin-12 and interleukin-6 gene polymorphisms and risk of bladder cancer in the Iranian population. Asian Pac J Cancer Prev. 2014;15(18):7869–73.

    Article  PubMed  Google Scholar 

  36. Kaarvatn MH, Vrbanec J, Kulic A, Knezevic J, Petricevic B, Balen S, et al. Single nucleotide polymorphism in the interleukin 12B gene is associated with risk for breast cancer development. Scand J Immunol. 2012;76(3):329–35.

    Article  CAS  PubMed  Google Scholar 

  37. Wang J, Nong L, Wei Y, Qin S, Zhou Y, Tang Y. Association of interleukin-12 polymorphisms and serum IL-12p40 levels with osteosarcoma risk. DNA Cell Biol. 2013;32(10):605–10.

    Article  PubMed  Google Scholar 

  38. Sima X, Xu J, Li Q, Luo L, Liu J, You C. Gene-gene interactions between interleukin-12A and interleukin-12B with the risk of brain tumor. DNA Cell Biol. 2012;31(2):219–23.

    Article  CAS  PubMed  Google Scholar 

  39. Pan XM, Sun RF, Li ZH, Guo XM, Zhang Z, Qin HJ, et al. A let-7 KRAS rs712 polymorphism increases colorectal cancer risk. Tumour Biol. 2014;35(1):831–5.

    Article  CAS  PubMed  Google Scholar 

  40. Gao LB, Li LJ, Pan XM, Li ZH, Liang WB, Bai P, et al. A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer. Biol Chem. 2013;394(3):415–20.

    Article  CAS  PubMed  Google Scholar 

  41. Li L, Pan X, Li Z, Bai P, Jin H, Wang T, et al. Association between polymorphisms in the promoter region of miR-143/145 and risk of colorectal cancer. Hum Immunol. 2013;74(8):993–7.

    Article  CAS  PubMed  Google Scholar 

  42. Li LJ, Pan XM, Sima X, Li ZH, Zhang LS, Sun H, et al. Interactions of interleukin-12A and interleukin-12B polymorphisms on the risk of intracranial aneurysm. Mol Biol Rep. 2012;39(12):11217–23.

    Article  CAS  PubMed  Google Scholar 

  43. Yuzhalin AE, Kutikhin AG. Interleukin-12: clinical usage and molecular markers of cancer susceptibility. Growth Factors. 2012;30(3):176–91.

    Article  CAS  PubMed  Google Scholar 

  44. Kalinski P, Hilkens CM, Snijders A, Snijdewint FG, Kapsenberg ML. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol. 1997;159(1):28–35.

    CAS  PubMed  Google Scholar 

  45. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003;3(2):133–46.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was funded by the National Natural Science Foundation of China (Nos. 81302149 and 81202387), the Ph.D. Programs Foundation of Ministry of Education of China (No. 20130181120011), Distinguished Young Scientist of Sichuan University (No. 2013SCU04A38), and the Science & Technology Pillar Program of Sichuan Province (Nos. 2014SZ0001 and 2013JY0013).

Conflicts of interest

None

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Author information

Author notes

    Authors and Affiliations

    1. Department of Immunology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, Sichuan, 610041, People’s Republic of China

      Ruifen Sun, Fang Yuan & Lin Zhang

    2. Central Laboratory, Yunnan University of Chinese Traditional Medicine, Kunming, 650500, Yunnan, People’s Republic of China

      Ruifen Sun

    3. Department of Orthopedics, National Clinical Key Specialty, Yanan Hospital, Kunming Medical University, Kunming, 650051, Yunnan, People’s Republic of China

      Fu Jia

    4. Laboratory of Molecular and Translational Medicine, West China Institute of Women and Children’s Health, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, 610041, People’s Republic of China

      Yundan Liang, Linbo Gao & Lin Zhang

    5. Key Laboratory of Obstetric and Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, 610041, People’s Republic of China

      Yundan Liang, Linbo Gao & Lin Zhang

    6. Department of Forensic Biology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, Sichuan, 610041, People’s Republic of China

      Lijuan Li & Peng Bai

    Authors
    1. Ruifen Sun
      View author publications

      Search author on:PubMed Google Scholar

    2. Fu Jia
      View author publications

      Search author on:PubMed Google Scholar

    3. Yundan Liang
      View author publications

      Search author on:PubMed Google Scholar

    4. Lijuan Li
      View author publications

      Search author on:PubMed Google Scholar

    5. Peng Bai
      View author publications

      Search author on:PubMed Google Scholar

    6. Fang Yuan
      View author publications

      Search author on:PubMed Google Scholar

    7. Linbo Gao
      View author publications

      Search author on:PubMed Google Scholar

    8. Lin Zhang
      View author publications

      Search author on:PubMed Google Scholar

    Corresponding authors

    Correspondence to Linbo Gao or Lin Zhang.

    Additional information

    Ruifen Sun and Fu Jia contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Sun, R., Jia, F., Liang, Y. et al. Interaction analysis of IL-12A and IL-12B polymorphisms with the risk of colorectal cancer. Tumor Biol. 36, 9295–9301 (2015). https://doi.org/10.1007/s13277-015-3685-7

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue date:

    • DOI: https://doi.org/10.1007/s13277-015-3685-7

    Keywords